Walder Wyss advises +ND Capital on its exit from CellPoint by sale to Galapagos

+ND Capital has exited Dutch cell therapy company CellPoint by sale to the Belgian biotech company Galapagos which has acquired CellPoint for $131 million upfront and up to $105 million in milestone payments.

As sole venture investor in CellPoint, a company dedicated to developing CAR-T therapies at the point-of-care, the sale underlines +ND Capital’s success in Europe, being its second exit after Arctos Medical sale to Novartis.

Headquartered in California, +ND Capital is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences. Currently they have over $500M under management and are currently investing our $335M third fund.

Walder Wyss has advised +ND Capital through its entire investment and in the sale transaction. The legal team was led by partner  Luc Defferrard (corporate/m&a, pictured) and included Michael Kündig (senior associate, corporate/m&a) and Alice Vorburger (associate, corporate/m&a).

Walder Wyss advises +ND Capital on its exit from CellPoint by sale to Galapagos

mercedes.galan

Legalcommunity.ch

Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram